Allergen Immunotherapy Adherence Not So Good

the MPR take:

For patients with allergic rhinitis who do not respond to pharmacotherapy, allergen immunotherapy may be an advisable treatment option. However, in a recent study published in the journal Annals of Allergy, Asthma & Immunology, only a small number of patients either initiated immunotherapy treatment or completed it. Patients in the study were given the option of either using sublingual drops or getting allergy shots. Some of the reasons for discontinuation included cost and side effects; however, the majority did not have a specific reason. Dr. Robert Anolik, who led the study, suggests using text messages and emails to keep patients on track with their treatment. Allergen immunotherapy, while underutilized, may be a viable option for patients who cannot get relief any other way.

People don't usually complete allergy shots or drops
People don't usually complete allergy shots or drops

Researchers also found that among patients who do begin so-called allergen immunotherapy, most don't complete the full course of therapy, which takes years. When symptoms aren't fully managed by allergy medications, doctors may suggest a course of allergen immunotherapy, which can include getting regular allergy shots or taking under-the-tongue (“sublingual”) drops at home for three to five years.